News & Analysis as of

Belgium › Healthcare

Hogan Lovells

The Belgian Federal Agency for Medicines and Health Products accelerates clinical trial evaluations to boost access to innovative...

Hogan Lovells on

Starting 1 January 2026, the Belgian Federal Agency for Medicines and Health Products (“AFMPS”) will implement accelerated evaluation timelines for initial applications for clinical trials involving medicines for human use....more

A&O Shearman

Belgian Competition Authority Issues Guidance on Information Exchange Between Pharmaceutical Companies for Combination Therapies

A&O Shearman on

On 10 September 2025, the Belgian Competition Authority (the BCA) published a communication clarifying the conditions under which pharmaceutical companies may exchange information specifically in the context of reimbursement...more

2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide